FINERENONE - AN OVERVIEW

Average or weak CYP3A4 Inhibitors: Keep an eye on serum potassium during drug initiation or dosage adjustment of both Kerendia or perhaps the reasonable or weak CYP3A4 inhibitor, and adjust Kerendia dosage as proper (7.1)To reduce the chance of key adverse cardiovascular gatherings (cardiovascular Loss of life, nonfatal myocardial infarction and no